Hydrogen-Rich Water Supplementation and Up-Hill Running Performance: Effect of Athlete Performance Level.
Michal Botek, Jakub Krejčí, Andrew J McKune, Barbora Sládečková · International journal of sports physiology and performance · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 16 participants, HRW for the 4 slowest runners (RT = 1490 [91] s) likely improved the RT (-36 to -3 s), whereas for the 4 fastest runners (RT = 1069 [53] s) the performance effect of HRW was unclear (-10 to 26 s). These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence fatigue-related outcomes.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in 16 participants. HRW for the 4 slowest runners (RT = 1490 [91] s) likely improved the RT (-36 to -3 s), whereas for the 4 fastest runners (RT = 1069 [53] s) the performance effect of HRW was unclear (-10 to 26 s).
What the Researchers Studied
The researchers studied 16 participants. The study used a randomized, double-blind, placebo-controlled, crossover human clinical trial. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
1680 mL hydrogen-rich water per reported dose; dissolved H₂ concentration was not reported in the available source text, so H2HUBB did not estimate milligrams of H₂. HRW for the 4 slowest runners (RT = 1490 [91] s) likely improved the RT (-36 to -3 s), whereas for the 4 fastest runners (RT = 1069 [53] s) the performance effect of HRW was unclear (-10 to 26 s).
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence fatigue-related outcomes and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a randomized, double-blind, placebo-controlled, crossover human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 16 participants. The reported sample size was 16. The study used a randomized, double-blind, placebo-controlled, crossover human clinical trial. The hydrogen delivery method was hydrogen-rich water. H2HUBB translates the reported hydrogen dose as 1680 mL hydrogen-rich water per reported dose; dissolved H₂ concentration was not reported in the available source text, so H2HUBB did not estimate milligrams of H₂.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.